Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition

Immunologic Research

Volumn 45, Issue 1, 2009, Pages 13-24

  Voss, Ching Y ^a   Deola, Sara ^a   Fleisher, Thomas A ^a   Marincola, Francesco M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adhesion molecules; Effector target conjugate formation; HLA restricted antigen recognition; Intracellular cytokines; TCR HLA epitopes

Indexed keywords

EPITOPE; HLA ANTIGEN; MELANOMA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL CLONE; CONJUGATION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANTIGEN PRESENTATION; CELL ADHESION; CELL LINE, TUMOR; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HLA-A ANTIGENS; HUMANS; IMMUNOLOGICAL SYNAPSES; INTERFERON-GAMMA; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 70349602784     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8041-1     Document Type: Article

References (22)

1. GG Luce SO Sharrow S Shaw PM Gallop 1985 Enumeration of cytotoxic cell-target cell conjugates by flow cytometry using internal fluorescent stains BioTechniques 3 270 2
2. P Perez J Bluestone DA Stephany DM Segal 1985 Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry J Immunol 134 478485
3. S Shaw GG Luce R Quinones, et al. 1986 Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones Nature 323 262 4 3093887 10.1038/323262a0 1:CAS:528:DyaL28XlvV2htb8%3D
4. S Shaw GEG Luce 1987 The lymphocyte function-associated antigen (LFA)-1 and CD2/LFA-3 pathways of antigen-independent human T cell adhesion J Immunol 139 1037 45 3302041 1:CAS:528:DyaL2sXlslersrs%3D
5. M Krogsgaard MM Davis 2005 How T cells "see" antigen (review) Nat immunol 6 239 45 15716973 10.1038/ni1173 1:CAS:528:DC%2BD2MXhtleqtL4%3D (Pubitemid 41724760)
6. ML Dustin TA Springer 1989 T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1 Nature 341 619 24 2477710 10.1038/341619a0 1:CAS:528:DyaL1MXmtlShtbg%3D (Pubitemid 19257309)
7. KL Mueller MA Daniels A Felthauser, et al. 2004 Cutting edge: LFA-1 integrin-dependent T cell adhesion is regulated by both antigen specificity and sensitivity J Immunol 173 2222 6 15294931 1:CAS:528:DC%2BD2cXmt1Omur8%3D
8. N Espagnolle D Depoil R Zaru, et al. 2007 CD2 and TCR synergize for the activation of phospholipase Cγ1/calcium pathway at the immunological synapse Int Immunol 19 239 48 17220479 10.1093/intimm/dxl141 1:CAS:528:DC%2BD2sXitFOqu7s%3D (Pubitemid 46344688)
9. EV Tibaldi R Salgia EL Reinherz 2002 CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance Pro Natl Acad Sci USA 99 7582 7 10.1073/pnas.112212699 1:CAS:528:DC%2BD38XktlCku7k%3D (Pubitemid 34568734)
10. L Rivoltini KC Barracchini V Viggiano, et al. 1995 Quantitative correlation between HLA Class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes Cancer Res 55 3149 57 7541714 1:CAS:528:DyaK2MXmvVyitLs%3D
11. Z Wang FM Marincola L Rivoltini, et al. 1999 Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells J Exp Med 190 205 15 10432284 10.1084/jem.190.2.205 1:CAS:528:DyaK1MXkslSjur4%3D (Pubitemid 29354914)
12. JN Cormier MC Panelli JA Hackett, et al. 1999 Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model Int J Cancer 80 781 90 10048982 10.1002/(SICI)1097- 0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A 1:CAS:528:DyaK1MXhtlSgtrk%3D (Pubitemid 29066293)
13. K-H Lee MC Panelli CJ Kim, et al. 1998 Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination J Immunol 161 4183 94 9780192 1:CAS:528:DyaK1cXmsF2jtb0%3D
14. + T cells following immunization Blood 104 1970 8 15187028 10.1182/blood-2004-02-0525 1:CAS:528:DC%2BD2cXotVOqtLg%3D (Pubitemid 39297845)
15. MR Parkhurst ML Salgaller S Southwood, et al. 1996 Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues J Immunol 157 2539 48 8805655 1:CAS:528:DyaK28Xls1aitr4%3D
16. G Jezzi E Scotet D Scheidegger A Lanzavecchia 1999 The interplay between the duration of TCR and cytokine signaling determines T cell polarization Eur J Immunol 29 4092 101 10.1002/(SICI)1521-4141(199912)29:12<4092::AID- IMMU4092>3.0.CO;2-A
17. D Segal DA Stephany 1984 The measurement of specific cell: cell interactions by dual-parameter flow cytometry Cytometry 5 169 81 6370631 10.1002/cyto.990050211 1:STN:280:DyaL2c7otF2luw%3D%3D
18. PJ Neeson PJ Thurlow GP Jamieson 2000 Characterization of activated lymphocyte-tumor cell adhesion J Leukoc Biol 67 847 55 10857858 1:CAS:528:DC%2BD3cXktFWmsbk%3D
19. LC Wu DS Tuot DS Lyons, et al. 2002 Two-step binding mechanism for T cell receptor recognition of peptide-MHC Nature 418 552 6 12152083 10.1038/nature00920 1:CAS:528:DC%2BD38Xls12nurc%3D (Pubitemid 34851403)
20. A Wiedemann D Depoil M Faroudi, et al. 2006 Cytotoxic T lymphocyte kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses Pro Natl Acad Sci USA 103 10985 90 10.1073/pnas.0600651103 1:CAS:528:DC%2BD28XnsFentL4%3D (Pubitemid 44148405)
21. + T cells J Immunol 168 5933 42 12023400 1:CAS:528:DC%2BD38XktFCrtb0%3D
22. TL Whiteside Y Zhao T Tsukishiro, et al. 2003 Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma Clin Can Res 9 641 9 1:CAS:528:DC%2BD3sXhtVKks7s%3D